| 1. |
Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease. Ann Intern Med, 2020, 173(3): ITC17-ITC32.
|
| 2. |
Landis SH, Muellerova H, Mannino DM, et al. Continuing to confront COPD international patient survey: methods, COPD prevalence, and disease burden in 2012-2013. Int J Chron Obstruct Pulmon Dis, 2014, 9: 597-611.
|
| 3. |
Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet, 2017, 389(10082): 1931-1940.
|
| 4. |
李薇, 楊汀, 王辰. 中國慢性阻塞性肺疾病防治現狀及進展. 中國研究型醫院, 2020, 7(5): 1-5.
|
| 5. |
Hu HY, Ji ZC, Qiang XY, et al. Chinese medical injections for acute exacerbation of chronic obstructive pulmonary disease: a network Meta-analysis. Int J Chron Obstruct Pulmon Dis, 2021, 16: 3363-3386.
|
| 6. |
Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med, 2008, 178(4): 332-338.
|
| 7. |
Zheng XY, Huang XB, Luo JM, et al. Effectiveness and tolerability of micafungin in Chinese patients with invasive fungal infections: a retrospective, multicenter study. Adv Ther, 2018, 35(9): 1400-1410.
|
| 8. |
中華醫學會呼吸病學分會慢性阻塞性肺疾病學組, 中國醫師協會呼吸醫師分會慢性阻塞性肺疾病工作委員會. 慢性阻塞性肺疾病診治指南(2021年修訂版). 中華結核和呼吸雜志, 2021, 44(3): 170-205.
|
| 9. |
肺真菌病診斷和治療專家共識. 中華結核和呼吸雜志, 2007, 30(11): 821-834.
|
| 10. |
Kidd AC, McGettrick M, Tsim S, et al. Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors. BMJ Open Respir Res, 2018, 5(1): e000240.
|
| 11. |
Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med, 2011, 155(3): 179-191.
|
| 12. |
Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health, 2015, 5(2): 020415.
|
| 13. |
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet, 2012, 380(9859): 2095-2128.
|
| 14. |
Schelenz S, Barnes RA, Barton RC, et al. British society for medical mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect Dis, 2015, 15(4): 461-474.
|
| 15. |
Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al. Diagnosis and management of aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect, 2018, 24 Suppl 1: e1-e38.
|
| 16. |
張黎, 蔣艷秋, 黃燕, 等. 慢性阻塞性肺疾病肺部侵襲性真菌感染危險因素及細胞因子基因多態性. 中華醫院感染學雜志, 2021, 31(13): 1930-1935.
|
| 17. |
高麗娜. 慢性阻塞性肺疾病繼發肺部真菌感染的危險因素分析. 現代醫學與健康研究電子雜志, 2021, 5(5): 121-123.
|
| 18. |
張秀明, 黃曉穎. 慢性阻塞性肺疾病急性加重期患者肺部真菌感染的相關因素分析. 數理醫藥學雜志, 2021, 34(9): 1285-1288.
|
| 19. |
王瑋琴, 金曉燕, 段玉香, 等. 慢性阻塞性肺疾病急性加重期患者醫院真菌感染危險因素分析. 中華醫院感染學雜志, 2019, 29(10): 1483-1486.
|
| 20. |
Fardet L, Petersen I, Nazareth I. Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study. PLoS Med, 2016, 13(5): e1002024.
|
| 21. |
Huckle AW, Fairclough LC, Todd I. Prophylactic antibiotic use in COPD and the potential anti-inflammatory activities of antibiotics. Respir Care, 2018, 63(5): 609-619.
|
| 22. |
Drummond RA, Desai JV, Ricotta EE, et al. Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria. Cell Host Microbe, 2022, 30(7): 1020-1033.
|
| 23. |
Hogan D, Lan LT, Diep DT, et al. Nutritional status of vietnamese outpatients with chronic obstructive pulmonary disease. J Hum Nutr Diet, 2017, 30(1): 83-89.
|
| 24. |
Nguyen HT, Collins PF, Pavey TG, et al. Nutritional status, dietary intake, and health-related quality of life in outpatients with COPD. Int J Chron Obstruct Pulmon Dis, 2019, 14: 215-226.
|
| 25. |
Hoong JM, Ferguson M, Hukins C, et al. Economic and operational burden associated with malnutrition in chronic obstructive pulmonary disease. Clin Nutr, 2017, 36(4): 1105-1109.
|
| 26. |
Dirks ML, Wall BT, van de Valk B, et al. One week of bed rest leads to substantial muscle atrophy and induces whole-body insulin resistance in the absence of skeletal muscle lipid accumulation. Diabetes, 2016, 65(10): 2862-2875.
|
| 27. |
Saudny-Unterberger H, Martin JG, Gray-Donald K. Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1997, 156(3 Pt 1): 794-799.
|
| 28. |
Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr, 2012, 95(6): 1385-1395.
|
| 29. |
Sun LD, Guo CS, Zhao ZY. Explore the influence of BMI in the optimal time of weaning from sequential mechanical ventilation for severity chronic obstructive pulmonary disease. BMC Emerg Med, 2013, 13 Suppl 1(Suppl 1): S1.
|
| 30. |
Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol, 2015, 16(4): e173-e180.
|
| 31. |
Gu Y, Ye XP, Liu YX, et al. A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease. Respir Res, 2021, 22(1): 176.
|